69 related articles for article (PubMed ID: 1725911)
1. Prevention of restenosis after PTCA: role of calcium antagonists.
Hoberg E; Kübler W
J Cardiovasc Pharmacol; 1991; 18 Suppl 6():S15-9. PubMed ID: 1725911
[TBL] [Abstract][Full Text] [Related]
2. Calcium-antagonists in preventing restenosis following coronary angioplasty.
Hoberg E; Kübler W
Cardiologia; 1991 Dec; 36(12 Suppl 1):225-7. PubMed ID: 1841774
[TBL] [Abstract][Full Text] [Related]
3. [Calcium antagonists and prevention of post-angioplasty restenosis].
Hoberg E
Arch Mal Coeur Vaiss; 1995 Sep; 88 Spec No 4():29-34. PubMed ID: 7503622
[TBL] [Abstract][Full Text] [Related]
4. [Inefficacy of diltiazem in restenosis prevention after coronary angioplasty].
Tanajura LF; Sousa AG; Feres F; Atallah T; Pinto IM; Centemero MP; Chaves AJ; Mattos LA; Martins HC; Abud RL
Arq Bras Cardiol; 1994 Feb; 62(2):99-102. PubMed ID: 7944997
[TBL] [Abstract][Full Text] [Related]
5. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty.
Schwartz L; Bourassa MG; Lespérance J; Aldridge HE; Kazim F; Salvatori VA; Henderson M; Bonan R; David PR
N Engl J Med; 1988 Jun; 318(26):1714-9. PubMed ID: 2967433
[TBL] [Abstract][Full Text] [Related]
6. Effects of amlodipine on ischemia after percutaneous transluminal coronary angioplasty: secondary results of the Coronary Angioplasty Amlodipine Restenosis (CAPARES) Study.
Jørgensen B; Thaulow E;
Am Heart J; 2003 Jun; 145(6):1030-5. PubMed ID: 12796759
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of calcium entry blockers during and after percutaneous transluminal coronary artery angioplasty.
Schlant RC; King SB
Circulation; 1989 Dec; 80(6 Suppl):IV88-92. PubMed ID: 2688988
[TBL] [Abstract][Full Text] [Related]
8. Effect of high dose verapamil on restenosis after peripheral angioplasty.
Schweizer J; Kirch W; Koch R; Hellner G; Uhlmann K
J Am Coll Cardiol; 1998 May; 31(6):1299-305. PubMed ID: 9581724
[TBL] [Abstract][Full Text] [Related]
9. Experimental and early clinical experience with reviparin-sodium for prevention of restenosis after percutaneous transluminal coronary angioplasty.
Preisack MB; Karsch KR
Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S55-8; discussion S59-60. PubMed ID: 8180331
[TBL] [Abstract][Full Text] [Related]
10. [The role of calcium antagonists on coronary artery spasm and prevention of restenosis after angioplasty].
Kocurek A; Piwowarska W
Przegl Lek; 1997; 54(1):37-42. PubMed ID: 9190633
[TBL] [Abstract][Full Text] [Related]
11. The effects of calcium antagonists after PTCA.
Hoberg E
Eur Heart J; 1995 Aug; 16 Suppl H():9-12. PubMed ID: 8846803
[TBL] [Abstract][Full Text] [Related]
12. Verapamil treatment after coronary angioplasty in patients at high risk of recurrent stenosis.
Hoberg E; Dietz R; Frees U; Katus HA; Rauch B; Schömig A; Schuler G; Schwarz F; Tillmanns H; Niebauer J
Br Heart J; 1994 Mar; 71(3):254-60. PubMed ID: 8142195
[TBL] [Abstract][Full Text] [Related]
13. The trapidil restenosis trial (STARC study): background, methods and clinical characteristics of the patient population.
Maresta A; Balducelli M; Cantini L; Casari A; Chioin R; Fontanelli A; Monici Preti PA; Repetto S; Raffaghello S
Clin Trials Metaanal; 1994 Apr; 29(1):31-40. PubMed ID: 10150183
[TBL] [Abstract][Full Text] [Related]
14. Probucol therapy in the prevention of restenosis after successful percutaneous transluminal coronary angioplasty.
Setsuda M; Inden M; Hiraoka N; Okamoto S; Tanaka H; Okinaka T; Nishimura Y; Okano H; Kouji T; Konishi T
Clin Ther; 1993; 15(2):374-82. PubMed ID: 8519045
[TBL] [Abstract][Full Text] [Related]
15. Restenosis after percutaneous transluminal coronary angioplasty in patients with non-insulin-dependent diabetes mellitus (NIDDM).
Asakura Y; Suzuki M; Nonogi H; Haze K; Sato A; Inada H; Okuda Y; Yamashita K; Harano Y
J Cardiovasc Risk; 1998; 5(5-6):331-4. PubMed ID: 9920005
[TBL] [Abstract][Full Text] [Related]
16. [The importance of serum lipid level for restenosis following initial successful percutaneous transluminal coronary angioplasty in patients with unstable angina].
Kishi K; Hiasa Y; Tanaka H; Tanimoto M; Kinoshita M; Shinohara A; Wada T; Aihara T
J Cardiol; 1996 Aug; 28(2):79-84. PubMed ID: 8814525
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous transluminal coronary angioplasty in the young patients--Siriraj Hospital's experience.
Singhaviranon L; Mahanonda N; Chotinaiwattarakul C; Chirapastan A; Kwo-Sa-Ard B; Tanapibunpon P; Kanabencha A; Jaidee T; Chaithiraphan S
J Med Assoc Thai; 2000 Nov; 83 Suppl 2():S199-205. PubMed ID: 11194015
[TBL] [Abstract][Full Text] [Related]
18. Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplasty.
Corcos T; David PR; Val PG; Renkin J; Dangoisse V; Rapold HG; Bourassa MG
Am Heart J; 1985 May; 109(5 Pt 1):926-31. PubMed ID: 3158187
[TBL] [Abstract][Full Text] [Related]
19. Verapamil: a review of its pharmacological properties and therapeutic use in coronary artery disease.
Brogden RN; Benfield P
Drugs; 1996 May; 51(5):792-819. PubMed ID: 8861548
[TBL] [Abstract][Full Text] [Related]
20. Results and clinical implications of the CAPARES trial.
Thaulow E; Jorgensen B
Can J Cardiol; 2000 Jul; 16 Suppl D():8D-11D. PubMed ID: 10932030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
